TORONTO -- Shares of cannabis company Cronos Group Inc. plummeted nearly 27 per cent after a U.S. short-seller raised concerns about the Toronto-based company's disclosures.
The company's stock fell $4.38 to $11.99 with nearly 10 million shares traded on the Toronto Stock Exchange after a brief halt in afternoon trading.
The selloff came after U.S.-based Citron Research published a report accusing the company of deceiving investors by purposely not disclosing the size of distribution agreements with provinces, unlike other major cannabis players.
Citron managing editor Andrew Left says unnamed sources have indicated the agreements are too small to justify the premium investors are paying for the stock.
Canada's cannabis stocks have been on a tear of late ahead of legalization of recreational use of marijuana on Oct. 17.
However, the health-care sector was down almost two per cent as several cannabis saw their stock prices fall.
Bagikan Berita Ini
Related Posts :
Lampert blames Sears Canada management for exacerbating the retailer's woes- Financial and industrials lead Toronto stock market higher, loonie down
- HBC selling Lord & Taylor building in New York for $1B, partners with WeWork
- HBC selling Lord & Taylor building in New York for US$850 million
- The thrill is gone ... Sears-Whirlpool split after 100 years
0 Response to "Cannabis company Cronos shares' lose 27% after Citron report"
Post a Comment